A comprehensive view of Biopharmaceuticals/Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Invectys partners with MD Anderson Cancer Center, Cell Therapy Manufacturing Center to develop process to create human leukocyte antigen targeted chimeric antigen receptor T cell therapy to treat solid tumors; process to use Invectys’ HLA-G platform
Published: June 21, 2022 by Marketline - Deals
Cell, gene therapy firm 4basebio collaborating with University of Alabama, Teesside University, to develop treatment for neurofibromatosis Type 1 that causes tumor growth on nerves; 4basebio to develop non-viral Hermes vector, hpDNA sequence as payload
Published: June 15, 2022 by Marketline - Deals
FDA approves Alnylam’s Amvuttra vutrisiran RNAi injectable to treat hereditary transthyretin-mediated amyloidosis in adults; in Phase 3 study drug stopped or reversed disease manifestation in more than 50% of patients
Published: June 15, 2022 by Business Wire
Charles River Laboratories partners with ASC Therapeutics to manufacture ASC618, a second-generation injectable gene therapy for hemophilia A; partnership will use Charles River’s end-to-end CDMO capabilities
Published: June 14, 2022 by Business Wire
GSK Immunotherapy Shows Promise As Alternative To Surgery In Certain Rectal Cancers
Published: June 09, 2022 by MedCityNews.com

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count